Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitrs in Lung Cancer: Case Report and Literature Review

por Xie, Wang, Hu, NaNa, Cao, LeJie
Publicado 2021

Case report: Indolent drug-related pneumonitis with alectinib therapy in the treatment of non-small cell lung cancer

por Chen, Xianmeng, Xia, Daqing, Jiang, Xuqin, Cao, Lejie, Ryu, Jay H., Hu, Xiaowen
Publicado 2022

The Impact of Afatinib on Survival in Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials

por Wang, Chi, Li, Yun, Ke, Li, Cao, Lejie, Fan, Pingsheng, Wu, Zhiwei, Wu, Quan
Publicado 2019

Suberoylanilide Hydroxamic Acid Treatment Reveals Crosstalks among Proteome, Ubiquitylome and Acetylome in Non-Small Cell Lung Cancer A549 Cell Line

por Wu, Quan, Cheng, Zhongyi, Zhu, Jun, Xu, Weiqing, Peng, Xiaojun, Chen, Chuangbin, Li, Wenting, Wang, Fengsong, Cao, Lejie, Yi, Xingling, Wu, Zhiwei, Li, Jing, Fan, Pingsheng
Publicado 2015

Results from the IMpower132 China cohort: Atezolizumab plus platinum‐based chemotherapy in advanced non‐small cell lung cancer

por Lu, Shun, Fang, Jian, Wang, Ziping, Fan, Yun, Liu, Yunpeng, He, Jianxing, Zhou, Jianying, Hu, Jie, Xia, Jinjing, Liu, Wenxin, Shi, Jane, Yi, Jing, Cao, Lejie
Publicado 2022

Pembrolizumab Plus Chemotherapy for Chinese Patients With Metastatic Squamous NSCLC in KEYNOTE-407

por Cheng, Ying, Zhang, Li, Hu, Jie, Wang, Donglin, Hu, ChengPing, Zhou, Jianying, Wu, Lin, Cao, Lejie, Liu, Jiwei, Zhang, Helong, Sun, Hong, Wang, Ziping, Gao, Hongjun, Sun, Yuping, Li, Ben, Hu, Xiaohan, Schwarzenberger, Paul, Paz-Ares, Luis
Publicado 2021

Envonalkib versus crizotinib for treatment-naive ALK-positive non-small cell lung cancer: a randomized, multicenter, open-label, phase III trial

por Yang, Yunpeng, Min, Jie, Yang, Nong, Yu, Qitao, Cheng, Ying, Zhao, Yanqiu, Li, Manxiang, Chen, Hong, Ren, Shou’an, Zhou, Jianying, Zhuang, Wu, Qin, Xintian, Cao, Lejie, Yu, Yan, Zhang, Jian, He, Jianxing, Feng, Jifeng, Yu, Hao, Zhang, Li, Fang, Wenfeng
Publicado 2023

Long-Term Efficacy, Safety, and Subgroup Analysis of Savolitinib in Chinese Patients With NSCLCs Harboring MET Exon 14 Skipping Alterations

por Lu, Shun, Fang, Jian, Li, Xingya, Cao, Lejie, Zhou, Jianying, Guo, Qisen, Liang, Zongan, Cheng, Ying, Jiang, Liyan, Yang, Nong, Han, Zhigang, Shi, Jianhua, Chen, Yuan, Xu, Hua, Zhang, Helong, Chen, Gongyan, Ma, Rui, Sun, Sanyuan, Fan, Yun, Fan, Songhua, Yu, Jie, Lu, Puhan, Luo, Xian, Su, Weiguo
Publicado 2022

Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phas...

por Yu, Yongfeng, Ren, Yongxin, Fang, Jian, Cao, Lejie, Liang, Zongan, Guo, Qisen, Han, Sen, Ji, Zimei, Wang, Ye, Sun, Yulan, Chen, Yuan, Li, Xingya, Xu, Hua, Zhou, Jianying, Jiang, Liyan, Cheng, Ying, Han, Zhigang, Shi, Jianhua, Chen, Gongyan, Ma, Rui, Fan, Yun, Sun, Sanyuan, Jiao, Longxian, Jia, Xiaoyun, Wang, Linfang, Lu, Puhan, Xu, Qian, Luo, Xian, Su, Weiguo, Lu, Shun
Publicado 2022

Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial

por Lu, Shun, Pan, Hongming, Wu, Lin, Yao, Yu, He, Jianxing, Wang, Yan, Wang, Xiuwen, Fang, Yong, Zhou, Zhen, Wang, Xicheng, Cai, Xiuyu, Yu, Yan, Ma, Zhiyong, Min, Xuhong, Yang, Zhixiong, Cao, Lejie, Yang, Huaping, Shu, Yongqian, Zhuang, Wu, Cang, Shundong, Fang, Jian, Li, Kai, Yu, Zhuang, Cui, Jiuwei, Zhang, Yang, Li, Man, Wen, Xinxuan, Zhang, Jie, Li, Weidong, Shi, Jianhua, Xu, Xingxiang, Zhong, Diansheng, Wang, Tao, Zhu, Jiajia
Publicado 2023

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade...

por Wu, Fengying, Jiang, Tao, Chen, Gongyan, Huang, Yunchao, Zhou, Jianying, Lin, Lizhu, Feng, Jifeng, Wang, Zhehai, Shu, Yongqian, Shi, Jianhua, Hu, Yi, Wang, Qiming, Cheng, Ying, Chen, Jianhua, Lin, Xiaoyan, Wang, Yongsheng, Huang, Jianan, Cui, Jiuwei, Cao, Lejie, Liu, Yunpeng, Zhang, Yiping, Pan, Yueyin, Zhao, Jun, Wang, LiPing, Chang, Jianhua, Chen, Qun, Ren, Xiubao, Zhang, Wei, Fan, Yun, He, Zhiyong, Fang, Jian, Gu, Kangsheng, Dong, Xiaorong, Zhang, Tao, Shi, Wei, Zou, Jianjun, Bai, Xuejuan, Ren, Shengxiang, Zhou, Caicun
Publicado 2022